FDA Provides Update On PSG Plans As 60 More Guidances Issued
US Regulator Offers Details Of Future Products To Be Covered
The latest update on product-specific guidances for generic development from the FDA included 60 new and newly-revised PSGs as well as an update on future guidances coming down the line in the next year.
